who shouldn t use glp 1 GLP-1 medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss GLP-1 Drugs and Eating Disorders:

Industry experts note that targeted combinations of research-selected strains working through complementary mechanisms may offer theoretical advantages over single-strain approaches or generic multi-strain probiotics without metabolic focus

As such, synthetic GLP-1/GCG co-agonists resistant to dipeptidyl peptidase-4 (DPP-4) proteolysis became an attractive target for anti-obesity treatments

Since Mounjaro was licensed for use for weight management in the UK in 2023 it has become the most widely used weight-loss drug

Complemented by a quantitative analysis, this qualitative analysis also identifies texts which have been influential in shaping the debate

In the limited number of MMNST cases reported, patients commonly presented with neuropathic symptoms such as pain and paresthesia, similar to the findings in this case